Obstetric antiphospholipid syndrome: still a challenge.
Obstetric complications such as fetal death, premature delivery, preeclampsia and recurrent abortions (since chromosomal or anatomic defects have been excluded) are characteristic manifestations of antiphospholipid syndrome (APS). They can occur in patients with known APS with previous arterial or venous events in any tissue or organ, or be its first and only manifestation. Pregnancy in a patient with APS is considered high risk and the full prenatal clinical follow-up must be carried with this in mind, eliminating or minimizing concomitant thrombotic risk factors.
Levy
R A
RA
Department of Rheumatology, Faculdade de Ciências Médicas, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil. roger.a.levy@gmail.com
Jesús
G R R
GR
Jesús
N R
NR
D000026:Abortion, Habitual / Q000209:etiology / Q000276:immunology; D000818:Animals; D017152:Antibodies, Antiphospholipid / Q000276:immunology; D016736:Antiphospholipid Syndrome / Q000150:complications* / Q000276:immunology; D005260:Female; D005313:Fetal Death / Q000209:etiology / Q000276:immunology; D006801:Humans; D011225:Pre-Eclampsia / Q000209:etiology / Q000276:immunology; D011247:Pregnancy; D011248:Pregnancy Complications / Q000209:etiology / Q000276:immunology*; D018566:Pregnancy, High-Risk / Q000276:immunology; D047928:Premature Birth / Q000209:etiology / Q000276:immunology; D012307:Risk Factors; D013927:Thrombosis / Q000209:etiology / Q000276:immunology
D017152:Antibodies, Antiphospholipid